Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 33 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 9475839

    Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  2. US 9468208

    Disease control with tick phospholipase A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted

  3. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  4. US 9463233

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  5. US 9458141

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  6. US 9457132

    Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  7. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  8. US 9452973

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  9. US 9446048

    Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  10. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  11. US 9441022

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  12. US 9441019

    Influenza hemagglutinin protein-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  13. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  14. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  15. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  16. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  17. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  18. US 9415116

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  19. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  20. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  21. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  22. US 9409994

    High-affinity monoclonal antibodies to glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  23. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  24. US 9402820

    Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.